India virus covid-19 vaccine DNA Coronavirus India

Covid-19 vaccine India update: PGI Rohtak to start phase-2 trial of Bharat Biotech's Covaxin

Reading now: 315
www.livemint.com

pic.twitter.com/VkFrkluQuaCovaxin is one of the frontrunners in the race for a Covid-19 vaccine in India. It is an “inactivated" vaccine — it works by injecting doses of the virus that have been killed aiming to prompt the body to build antibodies against it without the virus posing a threat.Each stage of a vaccine’s clinical trial tests its safety and ability to develop an effective immune response.

Phase 1 focuses on determining safety and dosage in a small group of healthy participants, while the second phase looks at the vaccine’s effectiveness.

The third phase looks into these aspects in a much larger population that would represent a wider demographic.Zydus Cadila's candidate based on viral DNA is the other Indian COVID-19 vaccines in.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA